On March 8, Haikou Children's Welfare Institution resonated with laughter as Huluwa Pharmaceutical Group, in collaboration with Hainan Xuridongsheng Charity Foundation, launched the “Growing Together, Painting Future” public welfare campaign. This marks the 9th consecutive year that Huluwa Pharmaceu

Huluwa Pharmaceutical Group has recently been awarded the AEO Certificate by Haikou Customs of the People's Republic of China, demonstrating its compliance with the high standards in global supply chain security management. This achievement further boosts the company's global expansion.

Huluwa Pharmaceutical Group was recognized as a “National Green Factory” for 2024, marking another significant milestone in its commitment to green, low-carbon, and sustainable development.Huluwa Pharmaceutical Group integrates green development principles throughout its entire production chain. The

On August 10, 2024, the much-anticipated 2024 CPEO (China Health Ecology Organization) opened at the Boao Forum in Hainan Province. During the event, Huluwa Pharmaceutical Group was recognized as one of the 2024 Top 50 Most Competitive Companies in the Proprietary Chinese Medicine Industry, a powerf

The much-anticipated 2023 China Medical and Health Industry Symbiosis Conference (MHIS), was held in Huzhou, Zhejiang Province, from June 25 to 28, 2023. More than 5,000 representative industrial experts, association leaders, and pharmaceutical entrepreneurs attended the conference to discuss on the

On the morning of April 25, the 2024 “New Quality Productive Forces Driving Long-Term Brand Growth” Science and Technology Forum & The Second Huluwa Science and Technology Association Annual Meeting were held in Haikou, Hainan province. The event aimed to establish a platform for collaboration betwe

On September 5, the 12th China Charity Award ceremony, sponsored by the Ministry of Civil Affairs, was held at the Great Hall of the People in Beijing on China Charity Day. Liu Jingping, Chairman of Huluwa Pharmaceutical Group, was honored with the 12th China Charity Award for her sustained dedicati

Huluwa Pharmaceutical (605119.SH) has released its 2022 annual report along with its Environmental, Social, and Governance (ESG) report. In 2022, Huluwa Pharmaceutical achieved a revenue of 1.515 billion yuan, marking an 11.91% year-on-year increase, while its net profit attributable to shareholders

Haikou, November 15, 2022 – At the Hainan Provincial Science and Technology Awards Conference, Huluwa Pharmaceutical Group was honored with the Second Prize of the Hainan Provincial Science and Technology Progress Award 2021 for its research project titled “Process Optimization of Xiao Er Fei Re Ke